According to Novartis India latest financial reports the cash on hand of NOVARTIND is $66.06M, an increase of 7.39% to 2022. At the end of 2022 company had $61.52M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $66.06M | 7.39% |
2022 | $61.52M | 3.80% |
2021 | $59.27M | -14.30% |
2020 | $69.16M | -4.93% |
2019 | $72.75M | - |